The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...

A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.

A large review of opioid pain relievers prescribed for acute pain has found these medicines provide only small, short-term ...

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

Chronic pain often gets the spotlight, but acute pain matters, too. Pain after surgery or an injury isn’t something to ignore or “power through” with the expectation that it’ll eventually go away.

Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...

Researchers found that opioids offer only limited pain relief for some pain conditions, such as dental surgery and traumatic ...

New phase 4 data from Vertex Pharmaceuticals revealed that more than 90% of patients recovering from aesthetic or reconstructive surgery remained opioid-free when treated with Journavx (suzetrigine) ...

If you’ve ever twisted your ankle, accidentally cut yourself, or had a toothache, you’ve probably experienced acute pain — a temporary sensation that usually comes on suddenly and can be intense.

Mental/emotional pain is processed in similar regions of the brain as physical pain, and both stimulate a flight-or-fight response. Nocioceptive pain refers only to the physical component of pain ...

In a laboratory at the Hebrew University of Jerusalem, Alexander Binshtok, a pain neurobiologist, and his group peer into rodent brains to understand the mechanisms of pain. But that isn’t what he ...